跳至主要内容
临床试验/EUCTR2006-000754-40-DE
EUCTR2006-000754-40-DE进行中(未招募)不适用

Interaktion von Statinen mit Clopidogrel als Sekundärprophylaxe bei der akuten zerebralen Ischämie - CLOPISTAT - CLOPISTAT

Dresden University of Technology0 个研究点目标入组 15 人开始时间: 2006年7月12日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age 40 – 80 years
  • - TIA or first ischemic stroke
  • - NIHSS < 5
  • - Serumcholesterol > 5 mmol/l, Serum-LDL-C > 3 mmol/l
  • - Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Pre- treatment with ASS or other anticoagulant medication within the last 6 weeks
  • - Pre-treatment with lipid-lowering agents within the last 6 weeks
  • - Thrombolysis in acute stroke
  • - Previous stroke
  • - Malignant systemic disease
  • - Dementia
  • - Bathel-Index > 1
  • - Known liver damage or persistent ellevation of liver enzymes
  • - Known or current abuse of drugs, medications or alcohol
  • - Subjects unlikely to comply with the requirements of the protocol
  • - Pregnancy or lactation
  • - Women with child-bearing potential, defined as all women physiologically capable of becoming pregnant, unless they meet the following definition of post-menopausal: 12 month of natural (spontaneous) amenorrhea or 6 weeks post surgical bilateral oophorectomy with or without hysterectomy or are using a highly effective method of birth control (defined as those which result in a low failure rate, i.e. less than 1% per year) when used consistently and correctly such as implants, injectables, combined oral contraceptives, some IUDs, sexual abstinence or vasectomized partner
  • - Participation in another clinical trial within the last 4 weeks

研究者

相似试验